Amphastar Pharmaceuticals
AMPH • NASDAQ
Amphastar Pharmaceuticals is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Yongfeng Zhang, with a market cap of $946.9M.
Market Cap$946.9M
Employees1.8K
CEOYongfeng Zhang
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
AMP
Amphastar Pharmaceuticals FAQ
Common questions about Amphastar Pharmaceuticals
Amphastar Pharmaceuticals is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $172.6M.
Amphastar Pharmaceuticals has approximately 1,761 employees.